These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 26474456)

  • 1. MDA-7/IL-24 functions as a tumor suppressor gene in vivo in transgenic mouse models of breast cancer.
    Menezes ME; Shen XN; Das SK; Emdad L; Guo C; Yuan F; Li YJ; Archer MC; Zacksenhaus E; Windle JJ; Subler MA; Ben-David Y; Sarkar D; Wang XY; Fisher PB
    Oncotarget; 2015 Nov; 6(35):36928-42. PubMed ID: 26474456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of Her2/Neu mammary tumor development in mda-7/IL-24 transgenic mice.
    Li YJ; Liu G; Xia L; Xiao X; Liu JC; Menezes ME; Das SK; Emdad L; Sarkar D; Fisher PB; Archer MC; Zacksenhaus E; Ben-David Y
    Oncotarget; 2015 Nov; 6(35):36943-54. PubMed ID: 26460950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MMTV mouse models and the diagnostic values of MMTV-like sequences in human breast cancer.
    Taneja P; Frazier DP; Kendig RD; Maglic D; Sugiyama T; Kai F; Taneja NK; Inoue K
    Expert Rev Mol Diagn; 2009 Jul; 9(5):423-40. PubMed ID: 19580428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion.
    Williams TM; Medina F; Badano I; Hazan RB; Hutchinson J; Muller WJ; Chopra NG; Scherer PE; Pestell RG; Lisanti MP
    J Biol Chem; 2004 Dec; 279(49):51630-46. PubMed ID: 15355971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tiam1-deficiency impairs mammary tumor formation in MMTV-c-neu but not in MMTV-c-myc mice.
    Strumane K; Rygiel T; van der Valk M; Collard JG
    J Cancer Res Clin Oncol; 2009 Jan; 135(1):69-80. PubMed ID: 18592271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of miR-489 derails mammary hierarchy structure and inhibits HER2/neu-induced tumorigenesis.
    Patel Y; Soni M; Awgulewitsch A; Kern MJ; Liu S; Shah N; Singh UP; Chen H
    Oncogene; 2019 Jan; 38(3):445-453. PubMed ID: 30104710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wnt signaling activation and mammary gland hyperplasia in MMTV-LRP6 transgenic mice: implication for breast cancer tumorigenesis.
    Zhang J; Li Y; Liu Q; Lu W; Bu G
    Oncogene; 2010 Jan; 29(4):539-49. PubMed ID: 19881541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral administration of a gemini vitamin D analog, a synthetic triterpenoid and the combination prevents mammary tumorigenesis driven by ErbB2 overexpression.
    So JY; Wahler JE; Yoon T; Smolarek AK; Lin Y; Shih WJ; Maehr H; Uskokovic M; Liby KT; Sporn MB; Suh N
    Cancer Prev Res (Phila); 2013 Sep; 6(9):959-70. PubMed ID: 23856074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cooperative signaling between Wnt1 and integrin-linked kinase induces accelerated breast tumor development.
    Oloumi A; Maidan M; Lock FE; Tearle H; McKinney S; Muller WJ; Aparicio SA; Dedhar S
    Breast Cancer Res; 2010; 12(3):R38. PubMed ID: 20565980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity.
    Cicchini M; Chakrabarti R; Kongara S; Price S; Nahar R; Lozy F; Zhong H; Vazquez A; Kang Y; Karantza V
    Autophagy; 2014; 10(11):2036-52. PubMed ID: 25483966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD24 Is Not Required for Tumor Initiation and Growth in Murine Breast and Prostate Cancer Models.
    Cremers N; Neeb A; Uhle T; Dimmler A; Rothley M; Allgayer H; Fodde R; Sleeman JP; Thiele W
    PLoS One; 2016; 11(3):e0151468. PubMed ID: 26978528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cooperating oncogenic events in murine mammary tumorigenesis: assessment of ErbB2, mutant p53, and mouse mammary tumor virus.
    Zelazny E; Li B; Anagnostopoulos AM; Coleman A; Perkins AS
    Exp Mol Pathol; 2001 Jun; 70(3):183-93. PubMed ID: 11417997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Generation and comparison of two genetically engineered mouse models of ErbB2/Neu positive-PTEN deficient breast cancer].
    Wang QF; Ding H; Liu BR; Zhang K
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2014 Jul; 43(4):427-33. PubMed ID: 25187457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated miRNA and mRNA expression profiling of mouse mammary tumor models identifies miRNA signatures associated with mammary tumor lineage.
    Zhu M; Yi M; Kim CH; Deng C; Li Y; Medina D; Stephens RM; Green JE
    Genome Biol; 2011 Aug; 12(8):R77. PubMed ID: 21846369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo analysis of mammary and non-mammary tumorigenesis in MMTV-cyclin D1 transgenic mice deficient in p53.
    Hosokawa Y; Papanikolaou A; Cardiff RD; Yoshimoto K; Bernstein M; Wang TC; Schmidt EV; Arnold A
    Transgenic Res; 2001 Oct; 10(5):471-8. PubMed ID: 11708657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained trophism of the mammary gland is sufficient to accelerate and synchronize development of ErbB2/Neu-induced tumors.
    Landis MD; Seachrist DD; Abdul-Karim FW; Keri RA
    Oncogene; 2006 Jun; 25(23):3325-34. PubMed ID: 16434967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated Akt1 accelerates MMTV-c-ErbB2 mammary tumourigenesis in mice without activation of ErbB3.
    Young CD; Nolte EC; Lewis A; Serkova NJ; Anderson SM
    Breast Cancer Res; 2008; 10(4):R70. PubMed ID: 18700973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of activated murine Notch1 and Notch3 in transgenic mice blocks mammary gland development and induces mammary tumors.
    Hu C; Diévart A; Lupien M; Calvo E; Tremblay G; Jolicoeur P
    Am J Pathol; 2006 Mar; 168(3):973-90. PubMed ID: 16507912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
    Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
    Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination with ErbB-2 peptides prevents cancer stem cell expansion and suppresses the development of spontaneous tumors in MMTV-PyMT transgenic mice.
    Gil EY; Jo UH; Lee HJ; Kang J; Seo JH; Lee ES; Kim YH; Kim I; Phan-Lai V; Disis ML; Park KH
    Breast Cancer Res Treat; 2014 Aug; 147(1):69-80. PubMed ID: 25104444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.